Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

Interagency Pain Research Coordinating Committee Meeting - November 2019

The Interagency Pain Research Coordinating Committee will hold its next meeting on November 18, 2019, and will be available on a videocast. For more information.  
Topics:

Bill to Help Prevent Drug Shortages Introduced by Senators Collins, Smith

U.S. Senator Susan Collins (R-ME), the Chairman of the Aging Committee, and Senator Tina Smith (D-MN) introduced the Mitigating Emergency Drug Shortages (MEDS) Act, legislation that would help increase the supplies of vi...
Continue reading

How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making?

This commentary responds to a case and examines pragmatic concerns about operating a busy outpatient practice in compliance with new laws that regulate opioid prescribing. Specifically, the article considers how regulati...
Continue reading

DEA Announces Additional Regulatory Steps to Address Opioid Epidemic

The Drug Enforcement Administration announced proposed regulations to improve DEA's ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further...
Continue reading
Topics:

Multisociety Pain Group Comments on Proposed Radiation Regulations in Colorado

AAPM participates in the Multisociety Pain Workgroup (MPW), a coalition of medical specialty societies, comprising physicians dedicated to pain management. This group convened to review and comment on the Colorado Board ...
Continue reading

DEA Warns of Alarming Increase of Scam Calls

  The Drug Enforcement Administration urges its DEA-registered practitioners and members of the public to be cautious of telephone calls (from a Salt Lake City area code) from criminals posing as DEA or other law en...
Continue reading
Topics:
DEA

HHS Announces Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use

  The U.S. Department of Health and Human Services (HHS) published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics . Individual patients, as well as t...
Continue reading

HHS Announces Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use

Today, the U.S. Department of Health and Human Services published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics - PDF . Individual patients, as well as t...
Continue reading

Noninvasive Nonpharmacological Treatments for Chronic Pain: An Update

The Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Noninvasive Nonpharmacological Treatments for Chronic Pai...
Continue reading
Topics:

AMA Responds to Walmart’s “Refusal to Fill” Policy

The American Medical Association (AMA) continues to express its concerns over Walmart's corporate prescription opioid restriction policy in its recent letter to Walmart's Chief Medical and Analytics Officer. The new policy limit opioid prescriptions to seven days or 50 morphine milligram equivalents (MME) has caused harm to patients with acute, palliative, cancer-related, chronic pain and other medical conditions requiring amounts or doses greater than the corporate policy. According to the AMA, "this policy has disrupted legitimate medical practices that receive form letters telling them their prescribing rights under state law will be superseded by a Walmart-created algorithm that deems a physician unfit to prescribe."

Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More